David Covert

2.2k total citations
47 papers, 1.7k citations indexed

About

David Covert is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Epidemiology. According to data from OpenAlex, David Covert has authored 47 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Ophthalmology, 15 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Epidemiology. Recurrent topics in David Covert's work include Glaucoma and retinal disorders (32 papers), Retinal Diseases and Treatments (30 papers) and Retinal Imaging and Analysis (10 papers). David Covert is often cited by papers focused on Glaucoma and retinal disorders (32 papers), Retinal Diseases and Treatments (30 papers) and Retinal Imaging and Analysis (10 papers). David Covert collaborates with scholars based in United States, Canada and United Kingdom. David Covert's co-authors include Alan L. Robin, Betsy Sleath, Jordana K. Schmier, Susan J. Blalock, Gary D. Novack, R. S. Crockett, Michael T. Halpern, Asheley Cockrell Skinner, Kelly W. Muir and Gail Tudor and has published in prestigious journals such as SHILAP Revista de lepidopterología, Ophthalmology and American Journal of Ophthalmology.

In The Last Decade

David Covert

47 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Covert United States 20 1.5k 584 472 141 139 47 1.7k
Hussein Hollands Canada 19 1.1k 0.7× 582 1.0× 55 0.1× 269 1.9× 15 0.1× 41 1.4k
P. Buchholz United States 15 665 0.4× 431 0.7× 289 0.6× 134 1.0× 30 0.2× 39 940
E Shyong Tai Singapore 17 412 0.3× 380 0.7× 84 0.2× 224 1.6× 8 0.1× 33 1.1k
Risa M. Wolf United States 20 213 0.1× 231 0.4× 63 0.1× 243 1.7× 8 0.1× 76 1.0k
Lin Zhao China 15 164 0.1× 81 0.1× 69 0.1× 123 0.9× 49 0.4× 54 815
Junhua Yu United States 11 106 0.1× 94 0.2× 360 0.8× 51 0.4× 2 0.0× 25 755
Hee Kwon South Korea 11 223 0.1× 150 0.3× 35 0.1× 17 0.1× 41 0.3× 21 440
Donna Eng United States 7 127 0.1× 72 0.1× 34 0.1× 35 0.2× 19 0.1× 9 510
Ian Peacock United Kingdom 15 52 0.0× 58 0.1× 52 0.1× 101 0.7× 6 0.0× 33 1.0k
C Kloos Germany 13 83 0.1× 85 0.1× 24 0.1× 119 0.8× 11 0.1× 73 603

Countries citing papers authored by David Covert

Since Specialization
Citations

This map shows the geographic impact of David Covert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Covert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Covert more than expected).

Fields of papers citing papers by David Covert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Covert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Covert. The network helps show where David Covert may publish in the future.

Co-authorship network of co-authors of David Covert

This figure shows the co-authorship network connecting the top 25 collaborators of David Covert. A scholar is included among the top collaborators of David Covert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Covert. David Covert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ogundele, Abayomi, et al.. (2018). Projected 24-hour post-dose ocular itching scores post-treatment with olopatadine 0.7% versus 0.2%. Journal of Pharmacokinetics and Pharmacodynamics. 45(4). 593–605. 3 indexed citations
2.
Viswanathan, Ananth C., et al.. (2017). Resource Utilization Among Glaucoma Patients in the UK Treated with Beta-Blocker and Non-Beta-Blocker Adjunctive Therapy: A Retrospective Cohort Analysis. Advances in Therapy. 34(7). 1695–1706. 3 indexed citations
3.
Schmier, Jordana K., et al.. (2016). An updated estimate of costs of endophthalmitis following cataract surgery among Medicare patients: 2010–2014. Clinical ophthalmology. Volume 10. 2121–2127. 14 indexed citations
4.
Schmier, Jordana K., et al.. (2016). Treatment costs of cystoid macular edema among patients following cataract surgery. Clinical ophthalmology. 10. 477–477. 27 indexed citations
5.
Schmier, Jordana K., David Covert, & Edmund Lau. (2012). Patterns and Costs Associated With Progression of Age-Related Macular Degeneration. American Journal of Ophthalmology. 154(4). 675–681.e1. 22 indexed citations
6.
Katz, Joanne, et al.. (2011). A Video Study of Drop Instillation in Both Glaucoma and Retina Patients with Visual Impairment. American Journal of Ophthalmology. 152(6). 982–988. 73 indexed citations
7.
Iskedjian, Michaël, David Covert, & John H. Walker. (2011). Persistence with Prostaglandin Agonist Use with and without Adjunctive Therapy for Glaucoma Patients. Patient. 4(2). 133–141. 4 indexed citations
8.
Schmier, Jordana K., David Covert, & Alan L. Robin. (2009). First-year treatment costs among new initiators of topical prostaglandin analogs. SHILAP Revista de lepidopterología. 6 indexed citations
9.
Sleath, Betsy, Susan J. Blalock, Alan L. Robin, et al.. (2009). Development of an instrument to measure glaucoma medication self-efficacy and outcome expectations. Eye. 24(4). 624–631. 41 indexed citations
10.
Stone, Jennifer, Alan L. Robin, Betsy Sleath, et al.. (2008). Compliance: An Objective Evaluation in Glaucoma Patients of Eye-Drop Instillation Using Video Observations and Patient Surveys. Investigative Ophthalmology & Visual Science. 49(13). 1580–1580. 3 indexed citations
11.
Schmier, Jordana K., David Covert, Gerald Matthews, & Z. N. Zakov. (2008). Impact of visual impairment on service and device use by individuals with diabetic retinopathy. Disability and Rehabilitation. 31(8). 659–665. 10 indexed citations
12.
Robin, Alan L., Abbot F. Clark, David Covert, et al.. (2008). Anterior Juxtascleral Delivery of Anecortave Acetate in Eyes with Primary Open-Angle Glaucoma: A Pilot Investigation. American Journal of Ophthalmology. 147(1). 45–50.e2. 18 indexed citations
13.
Robin, Alan L., et al.. (2007). A Comparison of Adherence to Glaucoma Medical Therapy for Patients on One Medication Compared to Two Different Medications Using a Computerized Medications Event Monitoring System (MEMS) Device. Investigative Ophthalmology & Visual Science. 48(13). 5574–5574. 1 indexed citations
14.
Schmier, Jordana K., Michael T. Halpern, David Covert, Edmund Lau, & Alan L. Robin. (2007). Evaluation of Medicare Costs of Endophthalmitis among Patients after Cataract Surgery. Ophthalmology. 114(6). 1094–1099. 23 indexed citations
15.
Schmier, Jordana K., Michael T. Halpern, David Covert, & Gerald Matthews. (2007). EVALUATION OF COSTS FOR CYSTOID MACULAR EDEMA AMONG PATIENTS AFTER CATARACT SURGERY. Retina. 27(5). 621–628. 71 indexed citations
16.
Halpern, Michael T., et al.. (2006). Resource utilization and costs of age-related macular degeneration.. PubMed. 27(3). 37–47. 19 indexed citations
17.
Covert, David & Alan L. Robin. (2006). Adjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprost. Current Medical Research and Opinion. 22(5). 971–976. 36 indexed citations
18.
Sleath, Betsy, Alan L. Robin, David Covert, et al.. (2006). Patient-Reported Behavior and Problems in Using Glaucoma Medications. Ophthalmology. 113(3). 431–436. 200 indexed citations
19.
Vicente, Colin, John Walker, Yvonne M. Buys, et al.. (2004). Association between mean intraocular pressure, disease stability and cost of treating glaucoma in Canada. Current Medical Research and Opinion. 20(8). 1245–1251. 11 indexed citations
20.
Halpern, Michael T., Sonja Sorensen, David Covert, & John E. Hutton. (2000). Longitudinal glaucoma treatment patterns with brinzolamide versus dorzolamide. Journal of Medical Economics. 3. 111–120. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hussein Hollands Breakdown of academic impact, for papers by P. Buchholz Breakdown of academic impact, for papers by E Shyong Tai Breakdown of academic impact, for papers by Risa M. Wolf Breakdown of academic impact, for papers by Lin Zhao Breakdown of academic impact, for papers by Junhua Yu Breakdown of academic impact, for papers by Hee Kwon Breakdown of academic impact, for papers by Donna Eng Breakdown of academic impact, for papers by Ian Peacock Breakdown of academic impact, for papers by C Kloos
Rankless by CCL
2026